


Revisionist History: Seat Belts & Resistance to Public Health Measures

The Dual-Target Strategy in Rheumatoid Arthritis: Put Patients First

In Memoriam: Remembering William R. Palmer, MD, MACR

In Memoriam: Ronald Olejko—May 4, 1950–Sept. 5, 2021

FDA Requires New Boxed Warnings on JAK Inhibitors, Places Restrictions on Use

Trial Pits Upadacitinib vs. Adalimumab for Psoriatic Arthritis

Tips for Transitioning Patients from Pediatric to Adult Rheumatology Care

Case Report: Is It Castleman Disease, or Castleman-Like?

New ACR Subcommittee Will Advance Diversity, Equity & Inclusion

RheumPAC Advocacy Fund: Effecting Change

ACR Responds to 2022 Medicare Physician Fee Schedule Proposed Rule

Supporting Women in Rheumatology

ACR Practice Experts Can Answer Challenging Business Questions

Updates in Pediatric Lupus: Experts Discuss Advances in Lupus Nephritis Treatments, Monogenic Lupus & More

Vasculitis Guidelines in Focus, Part 2: ANCA-Associated Vasculitis

Who You Know Matters … But Not with the ARP

Ethics Forum: To Test or Not to Test?

Fall 2021’s Awards, Appointments & Announcements in Rheumatology
